Alvotech and Teva Pharmaceuticals (United States)

Alvotech, in partnership with Teva Pharmaceuticals, develops and commercializes high-quality biosimilar medications. The collaboration focuses on bringing affordable biosimilar alternatives to expensive biologic drugs, including treatments for autoimmune diseases, oncology, and ophthalmology. Products include AVT02, a biosimilar to Humira (adalimumab). The partnership aims to increase patient access to life-changing biologic therapies through cost-effective biosimilar options.